Investors weighing growth in snacks against the stability of hygiene products must decide whether Hershey (HSY -0.85%) or Kimberly-Clark (KMB -0.95%) offers the most compelling path forward for a diversified portfolio.
Industry observers note that while Hershey is defined by its dominance in the chocolate and snack markets, Kimberly-Clark focuses on essential personal care and tissue products. These businesses are often compared because they both provide products that consumers tend to buy regardless of economic conditions, making them staples for many long-term investment portfolios.
In a recent development, hershey sells chocolate, sweets, and mints in more than 65 countries under more than 85 brand names. Its core strength lies in North American confectionery and salty snacks through iconic brands like Hershey's and Reese's. In its latest annual report, the company identified McLane Company, Inc. as its largest customer, representing nearly 27% of net sales. Customer concentration like this adds a layer of risk to the business, as this single distributor serves as the primary gateway to large retailers like Walmart Inc.
Reliable recent quarterly figures for at least one of these companies aren't available, so this comparison uses each company's latest full fiscal year. For the fiscal year ended in 2025, Hershey generated revenue of nearly $11.7 billion, representing roughly 4.4% growth over the prior year. Despite the top-line increase, the company reported net income of approximately $883.3 million, down from the $2.2 billion earned in fiscal 2024.
Industry observers note that as of its December 2025 balance sheet, the tech giant maintained a debt-to-equity ratio of approximately 1.2x. This ratio measures total debt relative to shareholders' equity, helping investors understand how much a firm relies on borrowed money. The current ratio, which compares short-term assets to short-term liabilities to assess liquidity, is roughly 1.2x. During the same period, Hershey generated free cash flow of nearly $1.7 billion, representing the cash remaining after the business covers its operating expenses and capital investments.
Kimberly-Clark operates in the consumer staples stocks arena, focusing on essential fiber-based and nonwoven products. Its portfolio includes household staples such as Huggies and Kleenex, with about half of its net sales coming from markets outside the U.S. Its largest customer is Walmart Inc., which accounted for nearly 16% of net sales in its most recent fiscal year. Customer concentration like this adds a layer of risk to the business, as a significant portion of volume relies on one retail partner.
In the fiscal year ended Dec. 31, 2025, the company reported revenue of close to $16.4 billion. This represented a revenue decrease of roughly 2.1% compared to the previous year. However, net income for the period reached approximately $2.0 billion. While revenue dipped slightly, this profit figure indicates resilience compared to the previous year, when net income was closer to $2.5 billion.
As of its December 2025 balance sheet, Kimberly-Clark carries a debt-to-equity ratio of approximately 4.9x. This indicates a greater reliance on debt than on equity in its capital structure, as total liabilities are significantly higher than shareholders' equity. The current ratio is close to 0.7x, suggesting that short-term liabilities exceed short-term assets. On a cash basis, the company generated free cash flow of roughly $1.6 billion, the cash left over after operating activities and capital expenditures are settled.
Industry observers note that hershey faces intense competition in the global snacking landscape, where rivals' potential integration of artificial intelligence could shift market dynamics. The company is also vulnerable to price volatility in key commodities, especially cocoa, which can squeeze net margin if costs cannot be passed to consumers. Furthermore, Hershey must manage the integration of newly introduced acquisitions like LesserEvil while navigating potential supply chain disruptions or labor strikes.
Recent findings suggest that kimberly-Clark is navigating the financial impact of substantial debt incurred to acquireΒ Kenvue. Successfully integrating these operations and capturing expected synergies is critical to its long-term health. The business also contends with pressure from private-label brands and fluctuations in raw material prices, such as pulp and petroleum. If a major pulp supplier such as Suzano (SUZ +1.09%) experiences market shifts, it could impact Kimberly-Clark's manufacturing costs and overall profitability.
Kimberly-Clark appears to be the more affordable option for investors, trading at a significantly lower Forward P/E based on future earnings estimates.
Valuation metrics include those sourced from Financial Modeling Prep (FMP) and may differ from those of other data providers.
While neither of these mature consumer goods stocks offers major multibagger potential anytime soon, Hershey and Kimberly-Clark present alluring 3.3% and 4.6% dividend yields, respectively, alongside stable operations. Though KMB stock's dividend yield is higher, it might be the more "swing-for-the-fences" style investment between the two companies, primarily because it offers potential upside from its hefty Kenvue acquisition.
According to recent reports, if Kimberly-Clark can successfully integrate its $49 billion acquisition of Kenvue and its wide array of global brands (such as Band-Aid, Tylenol, Listerine, Zyrtec, and Pepcid), it could soar past its meager forward P/E ratio of 16. This is especially true because management believes adjusted earnings per share will grow in the mid- to high-single digits over the next couple of years.
In a recent development, however, I would only consider buying The Hershey Company because I believe the stock offers better long-term compounding potential. Hershey has an unshakable chocolate business, a promptly growing salty snacks unit that it expects to become the No. 2 player over time, and ample international expansion potential.
While GLP-1s pose a threat to Hershey's operations, I think this fear is overdone, as the manufacturer could, counterintuitively, thrive on the peptide's rise to prominence, since miniaturization and smaller-pack sales typically offer higher margins for Hershey. Furthermore, Hershey boasts a better track record of integrating acquisitions, maintains a healthier balance sheet, and has more room to keep raising its dividend payments.
Ultimately, I don't love either stock's odds of beating the market over the next decade, but Hershey could be a great steady-Eddie pick for investors seeking a growing dividend in an increasingly volatile investing environment as we approach 2027.
Industry observers note that when our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 823%* β a market-crushing outperformance compared to 209% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
*Stock Advisor returns as of November 17, 2026.
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
It has been revealed that invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
